Heme allocation and disruptions in asthma and the failing heart

哮喘和心脏衰竭中的血红素分配和干扰

• 批准号: 10542447
• 负责人: Elizabeth A. Sweeny
• 金额: $ 24.9万
• 依托单位: MEDICAL COLLEGE OF WISCONSIN
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-01-01 至 2024-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10542447
• 关键词: Actins; Affect; Asthma; Atrial Fibrillation; Biochemical; Biological Assay; Blood Vessels; Calcium; Calcium Signaling; Cardiac Myocytes; Cardiovascular Diseases; Cardiovascular system; Cause of Death; Cell model; Cell physiology; Cells; Cessation of life; Cytoskeleton; Data; Diabetes Mellitus; Disease; Disease Progression; Enzymes; Family; Gene Expression; Heart; Heart failure; Heme; Hemeproteins; Homeostasis; Immunity; Link; Malignant Neoplasms; Membrane; Metabolism; Mitochondria; Molecular; NADPH Oxidase; Oxidation-Reduction; Pathologic; Patients; Phase; Physiological; RNA; Regulation; Role; Signal Transduction; Sinus; Stimulus; Stroke; Superoxides; System; Testing; Tissues; United States; Work; biological adaptation to stress; cardiovascular health; drug discovery; human disease; induced pluripotent stem cell derived cardiomyocytes; knock-down; member; novel; overexpression; prevent; protein expression; protein protein interaction; reconstitution; release of sequestered calcium ion into cytoplasm; response; structural biology

The heme protein NADPH oxidase 5 (NOX5) is a transmembrane signaling enzyme which produces superoxide in response to elevated intracellular calcium levels and is emerging as an exciting player in immunity and the cardiovascular system. NOX5 is crucial for proper vascular contraction and appears to be a nexus between cellular redox and calcium signaling, As the most recently discovered member of the NOX family of enzymes, details of NOX5 regulation and its role in the cell remain poorly resolved. It has, however, been implicated in numerous human diseases including cancers, diabetes and cardiovascular disorders. Elucidating details of NOX5 regulation and its role in cardiovascular health and disease is crucial to our understanding of normal cellular functions and how these become disrupted in disease. Based on preliminary data from the K99 phase, the R00 phase will focus on investigating the role of NOX5 in cardiomyocyte function and its contribution to the initiation and progression of atrial fibrillation (AF) (Aim 1) and to probe the significance of novel protein:protein interactions identified in the K99 phase which link NOX5 and the actin cytoskeleton, mitochondria, RNA regulation and stress response systems (Aim 2). Aim 1 will focus on understanding how NOX5 knockdown and overexpression affect gene and protein expression, calcium flux, and cellular metabolism in induced pluripotent stem cell (iPSC) derived cardiomyocytes, and then using patient tissue from hearts in AF or sinus rhythm to test hypothesizes generated from the iPSC derived cardiomyocyte system. Aim 2 will use a model cell system (HEK293 cells and HEK293 cells overexpressing NOX5) as well as iPSC derived cardiomyocytes to probe the interactome of NOX5 in response to stimuli and to understand how these interactions affect NOX5 activity and localization, the actin cytoskeleton, calcium flux, cellular metabolism, gene expression and the stress response system. This project will uncover crucial details about the role of NOX5 in the heart and in the broader context of cellular homeostasis. It will also lay important groundwork for identifying molecular factors responsible for the switch between physiological and pathological responses and identify interactions and interaction networks ideal for further study using purified components for use in reconstitution assays, structural biology projects, mechanistic studies using biochemical approaches and drug discovery projects.

血红素蛋白NADPH氧化酶5 （NOX5）是一种跨膜信号转导酶